Target intelligence / Profile preview

Parainfluenza Virus Type 3 (HPIV-3)

Target
HPIV-3
Molecular classification
Virus, Paramyxoviridae
01

Overview

Parainfluenza virus type 3 (HPIV-3) is a member of the Paramyxoviridae family and a significant cause of respiratory tract infections, particularly in infants, young children, older adults, and immunocompromised individuals. It spreads via respiratory droplets and is associated with illnesses such as bronchiolitis, bronchitis, and pneumonia. There is currently no approved vaccine.

Other names
PIV3Human parainfluenza virus type 3Human respirovirus 3
02

Biological functions

Viral replicationInfectionRespiratory infection
03

Disease associations

BronchiolitisBronchitisPneumoniaRespiratory tract infection
04

Safety considerations

Risk of severe lower respiratory tract infection in infants, young children, older adults, and immunocompromised individualsPotential for outbreaks in congregate settingsReinfection is possible despite prior exposure

Beyond the preview

Go deeper on Parainfluenza Virus Type 3 (HPIV-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parainfluenza Virus Type 3 (HPIV-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call